Abstract:
Neonatal lupus erythematosus (NLE) occurs due
to transplacental transfer of autoantibodies in
newborns of mothers with clinical or subclinical
collagen vascular diseases. Anti-Ro/SSA antibodies
are strongly associated with NLE. Anti-La/SSB and
anti-U1
-RNP antibodies are less frequent. Cutaneous and cardiac manifestations are prominent
of NLE. Nearly half of the cases show either cutaneous or cardiac features, and 10% show both. Skin
lesions may be congenital or develop within 12–16
weeks postpartum